NASDAQ:CDNA
CareDx, Inc.
CareDx, Inc.'s revenue grew 13.8% in fiscal 2025 to $379.8M while operating margin fell to −8.1%. The diluted share count fell 5.9%.Summary generated from CareDx, Inc.'s SEC filings. Latest annual report filed Feb 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$379.8M
Revenue growth+13.8%
Revenue, 5-yr CAGR+14.6%
Gross marginn/a
Operating margin−8.1%
Net margin−5.6%
ROICn/a
Return on equity−6.3%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change−5.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 296 | 322 | 280 | 334 | 380 |
| Operating income | −30 | −77 | −203 | 41 | −31 |
| Net income | −31 | −77 | −190 | 53 | −21 |
| Free cash flow | n/a | n/a | n/a | n/a | n/a |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 4Insider transaction report
Oct 5, 2026 - 8-K/AAmended completion of an acquisition or disposition
Sep 16, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 30, 2026 - 8-KResults of operations and financial condition
Jul 30, 2026 - 8-KCompletion of an acquisition or disposition
Jul 7, 2026 - 8-KDirector or officer change
Jun 15, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
Apr 28, 2026